MOTS-C

Mitochondrial & MetabolicResearch Use Only

Also known as: MOTSc, mitochondrial-derived peptide

MOTS-C is a mitochondrial-derived peptide commonly referenced in metabolic and exercise-physiology research literature. Studies describe its association with cellular energy regulation and metabolic homeostasis pathways such as AMPK signaling. It is frequently discussed in the context of aging and metabolic stress research.

Typical range (research)

Research literature references vary; commonly cited reference points fall in the ~5–10 mg per week range across studies

Half-life

Short (reported; exact values vary in literature)

Route

Subcutaneous (research)

Common use

Mitochondrial and metabolic research

Common vial sizes

5 mg · 10 mg · 20 mg · 40 mg

Storage

Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.

Stacking notes

Sometimes referenced in research discussions alongside other mitochondrial or metabolic compounds such as SS-31 or NAD+; combinations are not well characterized.

Reported side effects

Injection-site reactions (reported)Limited human safety data

Regulatory note: Not approved as a therapeutic drug in Canada or the US; investigational research compound. Research-grade material is not for human use.

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.